Key points are not available for this paper at this time.
Despite progress in diagnosis, treatment and care in recent years, RD patients globally have higher mortality rates and reduced survival compared to the general population, with specific variations according to gender, age and disease group.
Mazzucato et al. (Fri,) studied this question.